Prosecution Insights
Last updated: April 19, 2026

Nalpropion Pharmaceuticals LLC

8 pending office actions

Portfolio Summary

8
Total Pending OAs
7
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18143254 Layered Pharmaceutical Formulations ARNOLD, ERNST V 1613 Final Rejection May 04, 2023
17739910 Methods for Treating Visceral Fat Conditions SCHMITT, MICHAEL J 1629 Final Rejection May 09, 2022
17717691 Increasing Drug Bioavailability In Naltrexone Therapy RICCI, CRAIG D 1611 Final Rejection Apr 11, 2022
17493160 Methods Of Treating Overweight And Obesity WEDDINGTON, KEVIN E 1629 Non-Final OA Oct 04, 2021
17346902 Methods Of Providing Weight Loss Therapy In Patients With Major Depression BAEK, BONG-SOOK 1611 Final Rejection Jun 14, 2021
17343326 Increasing Drug Bioavailability In Naltrexone Therapy RICCI, CRAIG D 1611 Final Rejection Jun 09, 2021
17336546 Methods For Reducing Binge Or Compulsive Eating IVANOVA, SVETLANA M 1627 Final Rejection Jun 02, 2021
17319882 Compositions And Methods For Reducing Food Cravings MCMILLIAN, KARA RENITA 1623 Final Rejection May 13, 2021

Managing Nalpropion Pharmaceuticals LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month